Baudax Bio Inc., of Malvern, Pa., appointed Arnold Baskies and Andrew Drechsler to its board.

Recce Pharmaceuticals Ltd., of Sydney, appointed Philip Sutton to its clinical advisory committee and head of the Helicobacter pylori stomach bacteria development program.

Xeris Pharmaceuticals Inc., of Chicago, appointed John P. Shannon president and chief operating officer.

No Comments